The present and future burden of urinary bladder cancer in the world

World Journal of Urology

Volumn 27, Issue 3, 2009, Pages 289-293

  Ploeg, Martine ^a   Aben, Katja K H ^b   Kiemeney, Lambertus A ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Oost   (Netherlands)

Author keywords

Burden; Changes; Incidence; Urinary bladder cancer; Worldwide

Indexed keywords

ARTICLE; BLADDER TUMOR; COST OF ILLNESS; FEMALE; FORECASTING; HEALTH; HUMAN; MALE;

COST OF ILLNESS; FEMALE; FORECASTING; HUMANS; MALE; URINARY BLADDER NEOPLASMS; WORLD HEALTH;

EID: 67349258581     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0383-3     Document Type: Article

References (26)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ (2007) Global cancer facts and figs 2007. American Cancer Society, Atlanta
2. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5.version 2.0. IARC Press, Lyon
3. Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 218:12-20. doi: 10.1080/03008880802285032
4. Crow P, Ritchie AW (2003) National and international variation in the registration of bladder cancer. BJU Int 92(6):563-566. doi: 10.1046/ j.1464-410X.2003.04421.x
5. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Cancer 89(3):630-639. doi: 10.1002/1097-0142(20000801)89:3<;630::AID-CNCR19>;3.0.CO;2-Q
6. Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M et al (2008) The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19(4):421-429. doi: 10.1007/ s10552-007-9104-7
7. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al (2008) SEER cancer statistics review, 1975-2005. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/19752005/, based on November 2007 SEER data submission, posted to the SEER website
8. Kiemeney LA, Lemmers FA, Verhoeven RH, Aben KK, Honing C, de NJ et al (2008) The risk of cancer in the Netherlands. Ned Tijdschr Geneeskd 152(41):2233-2241
9. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44(10):1345-1389. doi: 10.1016/j.ejca.2007.12.015
10. Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P et al (2008) Declining mortality from bladder cancer in Europe. BJU Int 101(1):11-19
11. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA et al (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407-1427
12. Lopez A, Collishaw N, Piha T (1994) A descriptive model of the cigarette epidemic in developed countries. Tob Control 3:242-247. doi: 10.1136/ tc.3.3.242
13. Mackay J, Eriksen M (2002) The tobacco atlas. World Health Organization, Geneva
14. European Commission DHaCP2 Tobacco or health in the European Union: past, present and future. ASPECT Consortium
15. Delclos GL, Lerner SP (2008) Occupational risk factors. Scand J Urol Nephrol Suppl 218:58-63. doi: 10.1080/03008880802284423
16. Kiemeney LA, Coebergh JW, Koper NP, van der Heijden LH, Pauwels RP, Schapers RF et al (1994) Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer 30A(8):1134-1137. doi: 10.1016/0959-8049(94)90472-3
17. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12):1435-1448. doi: 10.1097/00000478-199812000-00001
18. Ezzati M, Lopez AD (2003) Estimates of global mortality attributable to smoking in 2000. Lancet 362(9387):847-852. doi: 10.1016/ S0140-6736(03)14338-3
19. Ezzati M, Lopez AD (2003) Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control 12(1):79-85. doi: 10.1136/tc.12.1.79
20. Shafey O, Dolwick S, Guindon GE (2003) Tobacco control country profiles. The 12th World Conference on Tobacco or Health
21. Carlyle J, Collin J, Muggli ME, Hurt RD (2004) British American Tobacco and formula one motor racing. BMJ 329(7457):104-106. doi: 10.1136/ bmj.329.7457.104
22. Dewhirst T, Hunter A (2002) Tobacco sponsorship of formula one and CART auto racing: Tobacco brand exposure and enhanced symbolic imagery through co-sponsors' third party advertising. Tob Control 11(2):146-150. doi: 10.1136/tc.11.2.146
23. El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, Nooman Z et al (2000) The epidemiology of schistosomiasis in Egypt: Summary findings in nine governorates. Am J Trop Med Hyg 62:88-99
24. Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy NM (2007) Bilharziasis and bladder cancer: A time trend analysis of 9843 patients. J Egypt Natl Cancer Inst 19(2):71-76
25. World Population Prospects (2007) The 2006 Revision. Exevutive Summary. United Nations, Department of Economic and Social Affairs
26. Wu X, Ros MM, Gu J, Kiemeney L (2008) Epidemiology and genetic susceptibility to bladder cancer. BJU Int 102:1207-1215. doi: 10.1111/ j.1464-410X.2008.07961.x